Thymic B-cell non-Hodgkin's lymphoma in a child
β Scribed by Azuma, Eiichi; Nishihara, Hidehiro; Qi, Jiang; Nagai, Masataka; Hiratake, Shinya; Zhang, Xiao-Li; Komada, Yoshihiro; Hamazaki, Minoru; Sakurai, Minoru
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 776 KB
- Volume
- 57
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
β¦ Synopsis
A 13-year-old male developed thymic non-Hodgkin's lymphoma. Microscopically, the tumor was composed of large cells, resembling centroblasts. Immunohistochemically, the tumor demonstrated leukocyte common antigen+, L26 (B-cell)+, UCHL1 (T-cell)-, suggesting the B-cell phenotype. In contrast to the terminally differentiated phenotype (CD10-, surface immunoglobulin-) observed in adult cases, flow cytometric analysis showed that they were relatively immature: CD10+, CD19+, HLA-DR-, IgM+/-, kappa+. He was successfully treated with intensive chemotherapy. Since childhood thymic lymphomas are exclusively small non-cleaved cell lymphoma with T-cell phenotype, this case represents a unique entity in children.
π SIMILAR VOLUMES
This study aimed to define the clinical characteristics, treatment outcome and independent prognostic factors of 144 patients with T-and 357 B-cell non-Hodgkin's lymphomas. Entities with well-defined immunophenotype and clinical characteristics were excluded. Patients with T-cell tumours were younge
## Background: Studies have shown telomerase activity to be present in some b-cell non-hodgkin lymphomas (b-nhls). however, no large studies have assayed telomerase activity in a systematic and quantitative manner. furthermore, the relation between telomerase and proliferation suggested by in vitro
## Abstract A young child with neurofibromatosis type 1 (NF1) is reported who developed two primary malignancies: a glioblastoma, followed 6 months later by an abdominal B cell nonβHodgkin's lymphoma. The child is now 4.5 years off treatment and disease free, but has developed progressive and sever